-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Medical Network, March 18, the National Health Commission and other five departments recently issued a document to include 12 diseases in the scope of treatment and management of childhood hematological diseases and malignant tumors, and encourage all regions to be included in the region on the basis of diseases determined by the country Major children's diseases frequently occurring and strongly reported by the masses
.
It is understood that these 12 diseases include glioma, medulloblastoma, craniopharyngioma, ependymoma, malignant germ cell tumor, nasopharyngeal carcinoma, thyroid cancer, pleuropulmonary blastoma, neurofibroma Disease, Langerhans cell histiocytosis, chronic active Epstein-Barr virus infection, and immune hemolytic anemia
.
The notice requires that all localities should promptly adjust and improve designated hospitals and diagnosis and treatment cooperation groups according to the needs of new disease types of diagnosis and treatment and case registration information data , refine diagnosis and treatment specifications and clinical pathways, improve medical security policies, and complete case information registration, Full management and follow-up
.
Children's blood diseases, malignant tumor disease more difficult to treat, part of the treatment process involves a number of diseases or medical disciplines, resulting in treatment cycles, high medical costs, low reimbursement, heavy family burdens
.
In 2019, the National Health Commission and other five departments included 10 major childhood hematological diseases and malignant tumors, including aplastic anemia, into the treatment management and guarantee system for the first time
.
.
It is understood that these 12 diseases include glioma, medulloblastoma, craniopharyngioma, ependymoma, malignant germ cell tumor, nasopharyngeal carcinoma, thyroid cancer, pleuropulmonary blastoma, neurofibroma Disease, Langerhans cell histiocytosis, chronic active Epstein-Barr virus infection, and immune hemolytic anemia
.
The notice requires that all localities should promptly adjust and improve designated hospitals and diagnosis and treatment cooperation groups according to the needs of new disease types of diagnosis and treatment and case registration information data , refine diagnosis and treatment specifications and clinical pathways, improve medical security policies, and complete case information registration, Full management and follow-up
.
Children's blood diseases, malignant tumor disease more difficult to treat, part of the treatment process involves a number of diseases or medical disciplines, resulting in treatment cycles, high medical costs, low reimbursement, heavy family burdens
.
In 2019, the National Health Commission and other five departments included 10 major childhood hematological diseases and malignant tumors, including aplastic anemia, into the treatment management and guarantee system for the first time
.
